Basic Information
Organo Therapeutics uses cutting-edge human-specific mini-brains to discover and develop effective candidate drugs for Parkinson's disease. We screen novel compounds that can treat different patient subgroups.
Organo Therapeutics
Luxembourg
less than 15 people
January 01, 2019
jens.schwamborn@organo-therapeutics.com
Enterprise Profile
Industrial Sector
Technology
Concept
Application Scenarios